Robert Haselbeck, PhD, is the Director of Microbiology at Persephone Biosciences, where he leads the company’s efforts in processing biological specimens for multi-omics analysis, isolating and characterizing novel gut microbes, and formulating the live biotherapeutic candidates. He previously held positions at Genomatica, Trius Therapeutics, and Elitra Pharmaceuticals. He obtained his PhD in biological sciences from the Univ. of California, Irvine, and has publications in various areas of microbiology, including target discovery for anti-infectives, yeast physiology, and metabolic engineering.
Director of Microbiology